Hep C Discussion Forum

Members Login
Username 
 
Password 
    Remember Me  
Chatbox
Please log in to join the chat!
Post Info TOPIC: Sales of Gilead`s Sovaldi Soar to $10.3 Billion


Guru

Status: Offline
Posts: 1781
Date:
RE: Sales of Gilead`s Sovaldi Soar to $10.3 Billion
Permalink  
 


Thanks Jill

I wonder what the over top Bonuses will be for the top execs of Gilead? Whom ever made the decision to over pay for the Pharmasset Sofosbuvir is due for a major bonus.

The old saying "its takes spending money to make money rings true in this case with Gilead" hopefully Gilead will fully develop all the HCV treatments to each 100% SVR for all Gene Types in the coming years as well as HBV they certainly have the money to do so.

I personally would like to Gilead institute a program for patients that have relapsed on there drugs to be retreated at no charge when a newer better version is released, it would go a long way in providing good will towards the HCV market and its patients.

matt   



__________________

"And in the end, the love you take is equal to the love you make"

61 year old Geno type A1, F4 Cirrhotic, started 24 weeks on Harvoni 12-17-14 ,EOT-5 week = UND, 8-31-15 =UND , SVR-24 Baby YES! 

Tig


Admin

Status: Offline
Posts: 9270
Date:
Permalink  
 

Thanks Jill,

Good grief.....I'm really crying in my fake beer over their trouble finding ways to spend all that money! How about some sort of dividend program for all of the HCV patients that ultimately made them rich? They could take a couple billion dollars of that money and make some people that suffered through trials, treatments, and tests very happy. I'm glad they have been so successful, but it came at a high cost for many and money wasn't their ultimate goal. But nonetheless, we are grateful for their accomplishments...

Tig



__________________

Tig

67yo GT1A - 5 Mil - A2/F3 - (1996) Intron A - Non Responder, (2013) Peg/Riba/Vic SOT:05/23/13 EOT:12/04/13 SVR 9+ years!

Hep C FAQ   Lab Ref. Ranges  HCV Resistance

Signature Line Set Up/Abbreviations   Payment Assistance

 



Guru

Status: Offline
Posts: 5629
Date:
Permalink  
 

Interesting article from the New York Times, if anyone would like to read it.

I had to smile at this sentence at the end..."Gilead now is faced with figuring out what to do with all the cash it is generating."  My heart bleeds for them!

http://www.nytimes.com/2015/02/04/business/sales-of-sovaldi-new-gilead-hepatitis-c-drug-soar-to-10-3-billion.html?ref=business&_r=0

 

 



__________________

Jill 

(71 yo, lives in UK)

Was Gen 3a, 

24wks Peg Ifn/Riba, Sep 2010 - Mch 2011

UND @ Wk.4, UND @ EOT, 

SVR Nov 2011 --> Still UND @ EOT + 4 yrs.

 

 

Page 1 of 1  sorted by
 
Quick Reply

Please log in to post quick replies.

Legal Disclaimer:

THIS FORUM, IT'S OWNERS, ADMINISTRATORS, MODERATORS AND MEMBERS DO NOT AT ANY TIME GIVE MEDICAL ADVICE AND IN ALL CASES REFER ANYONE HERE TO SEEK APPROPRIATE MEDICAL ADVICE FROM THEIR DOCTOR.